Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cyclosporine Mitigated the Augmented Serum Level of IL-33 in Egyptian Psoriatic Patients in Relation to Disease Severity

NCT07557095 is registered in ClinicalTrials.gov with scientific_committee as lead sponsor.

NCT NCT07557095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07557095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cyclosporine Mitigated the Augmented Serum Level of IL-33 in Egyptian Psoriatic Patients in Relation to Disease Severity
Lead sponsor
scientific_committee
Phase
Observational
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
March 1, 2027
Enrollment
118 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

egyptian psoriatic patients